QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
INTEVAC, INC.
INDEX
2
Item 1. |
Financial Statements |
July 1, 2023 |
December 31, 2022 |
|||||||
(Unaudited) |
||||||||
(In thousands, except par value) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Short-term investments |
||||||||
Trade and other accounts receivable, net of allowances of $ |
||||||||
Inventories |
||||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
Long-term investments |
||||||||
Restricted cash |
||||||||
Property, plant and equipment, net |
||||||||
Operating lease right-of-use-assets |
||||||||
Intangible assets, net of amortization of $ |
||||||||
Deferred income taxes and other long-term assets |
||||||||
Total assets |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Current operating lease liabilities |
$ | $ | ||||||
Accounts payable |
||||||||
Accrued payroll and related liabilities |
||||||||
Other accrued liabilities |
||||||||
Customer advances |
||||||||
Total current liabilities |
||||||||
Noncurrent liabilities: |
||||||||
Noncurrent operating lease liabilities |
||||||||
Customer advances |
||||||||
Other noncurrent liabilities |
||||||||
Total noncurrent liabilities |
||||||||
Stockholders’ equity: |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Treasury stock, |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
Note: | Amounts as of December 31, 2022 are derived from the December 31, 2022 audited consolidated financial statements. |
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(Unaudited) |
||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||
Net revenues |
$ | $ | $ | $ | ||||||||||||
Cost of net revenues |
||||||||||||||||
Gross profit |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Total operating expenses |
||||||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Interest income and other income (expense), net |
||||||||||||||||
Loss from continuing operations before provision for income taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Provision for income taxes |
||||||||||||||||
Net loss from continuing operations, net of taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net income (loss) from discontinued operations, net of taxes |
( |
) | ( |
) | ||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Net income (loss) per share: |
||||||||||||||||
Basic and diluted – continuing operations |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Basic and diluted – discontinued operations |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
Basic and diluted – net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic and diluted |
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(Unaudited) |
||||||||||||||||
(In thousands) |
||||||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss), before tax: |
||||||||||||||||
Change in unrealized net gain (loss) on available-for-sale |
( |
) | ( |
) | ||||||||||||
Foreign currency translation losses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other comprehensive income (loss), before tax |
( |
) | ( |
) | ( |
) | ||||||||||
Income taxes related to items in other comprehensive income (loss) |
||||||||||||||||
Other comprehensive income (loss), net of tax |
( |
) | ( |
) | ( |
) | ||||||||||
Comprehensive loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Six months ended |
||||||||
July 1, 2023 |
July 2, 2022 |
|||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
Operating activities |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Amortization of intangible assets |
||||||||
Net amortization (accretion) of investment premiums and discounts |
( |
) | ( |
) | ||||
Equity-based compensation |
||||||||
Straight-line rent adjustment and amortization of lease incentives |
( |
) | ( |
) | ||||
Deferred income taxes |
||||||||
(Gain) loss on disposal of equipment |
( |
) | ||||||
Changes in operating assets and liabilities |
( |
) | ( |
) | ||||
Total adjustments |
( |
) | ( |
) | ||||
Net cash and cash equivalents used in operating activities |
( |
) | ( |
) | ||||
Investing activities |
||||||||
Purchases of investments |
( |
) | ( |
) | ||||
Proceeds from sales and maturities of investments |
||||||||
Proceeds from sales of fixed assets |
||||||||
Purchases of leasehold improvements and equipment |
( |
) | ( |
) | ||||
Net cash and cash equivalents provided by (used in) investing activities |
( |
) | ||||||
Financing activities |
||||||||
Net proceeds from issuance of common stock |
||||||||
Payment of acquisition-related contingent consideration |
( |
) | ||||||
Taxes paid related to net share settlement |
( |
) | ( |
) | ||||
Net cash and cash equivalents provided by (used in) financing activities |
( |
) | ||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | ( |
) | ||||
Net decrease in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
Cash, cash equivalents and restricted cash at beginning of period |
||||||||
Cash, cash equivalents and restricted cash at end of period |
$ | $ | ||||||
Non-cash investing and financing activity |
||||||||
Additions to right-of-use-assets |
$ | $ | ||||||
1. |
Description of Business, Basis of Presentation and Significant Accounting Policy |
2. |
Divestiture and Discontinued Operations |
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
Selling, general and administrative |
$ | ( |
) | $ | $ | ( |
) | $ | ||||||||
Total operating expenses |
( |
) | ( |
) | ||||||||||||
Operating income (loss) – discontinued operations |
( |
) | ( |
) | ||||||||||||
Other income (expense) – discontinued operations |
||||||||||||||||
Income (loss) from discontinued operations before provision for income taxes |
( |
) | ( |
) | ||||||||||||
Provision for income taxes |
||||||||||||||||
Net income (loss) from discontinued operations, net of taxes |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
Equity-based compensation |
$ | $ | $ | ( |
) | $ | ( |
) |
3. |
Revenue |
Three Months Ended July 1, 2023 |
Three Months Ended July 2, 2022 |
|||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||
HDD |
PV |
ASP |
Total |
HDD |
DCP |
PV |
Total |
|||||||||||||||||||||||||
Systems, upgrades and spare parts |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Field service |
||||||||||||||||||||||||||||||||
Total net revenues |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Six Months Ended July 1, 2023 |
Six Months Ended July 2, 2022 |
|||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||
HDD |
PV |
ASP |
Total |
HDD |
DCP |
PV |
Total |
|||||||||||||||||||||||||
Systems, upgrades and spare parts |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Field service |
||||||||||||||||||||||||||||||||
Total net revenues |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
United States |
$ | $ | $ | $ | ||||||||||||
Asia |
||||||||||||||||
Europe |
||||||||||||||||
Total net revenues |
$ | $ | $ | $ | ||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
Products transferred at a point in time |
$ | $ | $ | $ | ||||||||||||
Products and services transferred over time |
||||||||||||||||
Total net revenues |
$ | $ | $ | $ | ||||||||||||
July 1, 2023 |
December 31, 2022 |
Six Months Change |
||||||||||
(In thousands) |
||||||||||||
Contract assets: |
||||||||||||
Accounts receivable, unbilled |
$ | $ | $ | |||||||||
Contract liabilities: |
||||||||||||
Deferred revenue |
$ | $ | $ | ( |
) | |||||||
Customer advances |
( |
) | ||||||||||
$ | $ | $ | ( |
) | ||||||||
4. |
Inventories |
July 1, |
December 31, |
|||||||
2023 |
2022 |
|||||||
(In thousands) |
||||||||
Raw materials |
$ | $ | ||||||
Work-in-progress |
||||||||
Finished goods |
||||||||
$ | $ | |||||||
5. |
Equity-Based Compensation |
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
Equity-based compensation by type of award: |
||||||||||||||||
Stock options |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||
RSUs |
||||||||||||||||
PRSUs |
||||||||||||||||
ESPP purchase rights |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total equity-based compensation |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(a) | A reversal of $ |
(b) | Equity-based compensation reported in discontinued operations of ($ |
Shares |
Weighted-Average Exercise Price |
|||||||
Options outstanding at December 31, 2022 |
$ | |||||||
Options cancelled and forfeited |
( |
) | $ | |||||
Options exercised |
( |
) | $ | |||||
|
|
|||||||
Options outstanding at July 1, 2023 |
$ | |||||||
|
|
|||||||
Options exercisable at July 1, 2023 |
$ | |||||||
|
|
Six Months Ended |
||||||||
July 1, 2023 |
July 2, 2022 |
|||||||
ESPP Purchase Rights: |
||||||||
Weighted-average fair value of grants per share |
$ | $ | ||||||
Expected volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Expected term of purchase rights (in years) |
||||||||
Dividend yield |
Shares |
Weighted-Average Grant Date Fair Value |
|||||||
Non-vested RSUs at December 31, 2022 |
$ | |||||||
Granted |
$ | |||||||
Vested |
( |
) | $ | |||||
Cancelled and forfeited |
( |
) | $ | |||||
|
|
|||||||
Non-vested RSUs at July 1, 2023 |
$ | |||||||
|
|
Shares |
Weighted-Average Grant Date Fair Value |
|||||||
Non-vested PRSUs at December 31, 2022 |
$ | |||||||
Granted |
$ | |||||||
Vested |
( |
) | $ | |||||
Cancelled and forfeited |
( |
) | $ | |||||
|
|
|||||||
Non-vested PRSUs at July 1, 2023 |
$ | |||||||
|
|
Three and Six Months Ended |
||||
July 2, 2022 |
||||
Weighted-average fair value of grants per share |
$ | |||
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Dividend yield |
6. |
Warranty |
Three Months Ended |
Six Months Ended |
|||||||||||||||
July 1, 2023 |
July 2, 2022 |
July 1, 2023 |
July 2, 2022 |
|||||||||||||
(In thousands) |
||||||||||||||||
Opening balance |
$ | $ | $ | $ | ||||||||||||
Expenditures incurred under warranties |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Accruals for product warranties issued during the reporting period |
||||||||||||||||
Adjustments to previously existing warranty accruals |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing balance |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
July 1 2023 |
December 31 2022 |
|||||||
(In thousands) |
||||||||
Other accrued liabilities |
$ | $ | ||||||
Other noncurrent liabilities |
||||||||
|
|
|
|
|||||
Total warranty provision |
$ | $ | ||||||
|
|
|
|
|
|
|
|
|
7. |
Guarantees |
8. |
Cash, Cash Equivalents and Investments |
July 1, 2023 |
||||||||||||||||
Amortized Cost |
Unrealized Holding Gains |
Unrealized Holding Losses |
Fair Value |
|||||||||||||
(In thousands) |
||||||||||||||||
Cash and cash equivalents: |
||||||||||||||||
Cash |
$ | $ | $ | $ | ||||||||||||
Money market funds |
||||||||||||||||
Commercial paper |
||||||||||||||||
Total cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Short-term investments: |
||||||||||||||||
Asset-backed securities |
$ | $ | $ | $ | ||||||||||||
Certificates of deposit |
||||||||||||||||
Commercial paper |
||||||||||||||||
Corporate bonds and medium-term notes |
||||||||||||||||
Municipal bonds |
||||||||||||||||
U.S. treasury securities |
||||||||||||||||
Total short-term investments |
$ | $ | $ | $ | ||||||||||||
Long-term investments: |
||||||||||||||||
Asset-backed securities |
$ | $ | $ | $ | ||||||||||||
Corporate bonds and medium-term notes |
||||||||||||||||
Total long-term investments |
$ | $ | $ | $ | ||||||||||||
Total cash, cash equivalents, and investments |
$ | $ | $ | $ | ||||||||||||
December 31, 2022 |
||||||||||||||||
Amortized Cost |
Unrealized Holding Gains |
Unrealized Holding Losses |
Fair Value |
|||||||||||||
(In thousands) |
||||||||||||||||
Cash and cash equivalents: |
||||||||||||||||
Cash |
$ | $ | $ | $ | ||||||||||||
Money market funds |
||||||||||||||||
Commercial paper |
||||||||||||||||
Total cash and cash equivalents |
$ | $ | $ | $ | ||||||||||||
Short-term investments: |
||||||||||||||||
Asset-backed securities |
$ | $ | $ | $ | ||||||||||||
Certificates of deposit |
||||||||||||||||
Commercial paper |
||||||||||||||||
Corporate bonds and medium-term notes |
||||||||||||||||
Municipal bonds |
||||||||||||||||
U.S. treasury securities |
||||||||||||||||
Total short-term investments |
$ | $ | $ | $ | ||||||||||||
Long-term investments: |
||||||||||||||||
Asset-backed securities |
$ | $ | $ | $ | ||||||||||||
Corporate bonds and medium-term notes |
||||||||||||||||
Municipal bonds |
||||||||||||||||
U.S. treasury and agency securities |
||||||||||||||||
Total long-term investments |
$ | $ | $ | $ | ||||||||||||
Total cash, cash equivalents, and investments |
$ | $ | $ | $ | ||||||||||||
Amortized Cost |
Fair Value |
|||||||
(In thousands) |
||||||||
Due in one year or less |
$ | $ | ||||||
Due after one through five years |
||||||||
$ | $ | |||||||
July 1, 2023 |
||||||||||||||||
In Loss Position for Less than 12 Months |
In Loss Position for Greater than 12 Months |
|||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||
(In thousands) |
||||||||||||||||
Asset-backed securities |
$ | $ | $ | $ | ||||||||||||
Certificates of deposit |
||||||||||||||||
Commercial paper |
||||||||||||||||
Corporate bonds and medium-term notes |
||||||||||||||||
Municipal bonds |
||||||||||||||||
U.S. treasury securities |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
Fair Value Measurements at July 1, 2023 |
||||||||||||
Total |
Level 1 |
Level 2 |
||||||||||
(In thousands) |
||||||||||||
Recurring fair value measurements: |
||||||||||||
Investment securities |
||||||||||||
Money market funds |
$ | $ | $ | |||||||||
U.S. treasury and agency securities |
||||||||||||
Asset-backed securities |
||||||||||||
Certificates of deposit |
||||||||||||
Commercial paper |
||||||||||||
Corporate bonds and medium-term notes |
||||||||||||
Municipal bonds |
||||||||||||
Total recurring fair value measurements |
$ | $ | $ | |||||||||
9. |
Derivative Instruments |
Notional Amounts |
Derivative Liabilities |
Derivative Assets |
||||||||||||||||||||||
Derivative Instrument |
July 1, 2023 |
December 31, 2022 |
July 1, 2023 |
December 31, 2022 |
||||||||||||||||||||
Balance Sheet Line |
Fair Value |
Balance Sheet Line |
Fair Value |
|||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||
Undesignated Hedges: |
||||||||||||||||||||||||
Forward Foreign Currency Contracts |
$ | b |
$ | a |
$ | |||||||||||||||||||
Total Hedges |
$ | $ | $ | |||||||||||||||||||||
a | Other current assets |
b | Other accrued liabilities |
10. |
Equity |
Three Months Ended July 1, 2023 |
||||||||||||||||||||
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||
Balance at April 1, 2023 |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Common stock issued under employee plans |
— | — | — | |||||||||||||||||
Shares withheld for net share settlement of RSUs |
( |
) | — | — | — | ( |
) | |||||||||||||
Equity-based compensation expense |
— | — | — | |||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
Other comprehensive loss |
— | — | ( |
) | — | ( |
) | |||||||||||||
Balance at July 1, 2023 |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Six Months Ended July 1, 2023 |
||||||||||||||||||||
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||
Balance at December 31, 2022 |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Common stock issued under employee plans |
— | — | — | |||||||||||||||||
Shares withheld for net share settlement of RSUs |
( |
) | — | — | — | ( |
) | |||||||||||||
Equity-based compensation expense |
— | — | — | |||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
Other comprehensive loss |
— | — | — | |||||||||||||||||
Balance at July 1, 2023 |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||
Three Months Ended July 2, 2022 |
||||||||||||||||||||
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||
Balance at April 2, 2022 |
$ | $ | ( |
) | $ | $ | ( |
) | $ | |||||||||||
Common stock issued under employee plans |
— | — | — | |||||||||||||||||
Shares withheld for net share settlement of RSUs |
( |
) | — | — | — | ( |
) | |||||||||||||
Equity-based compensation expense |
— | — | — | |||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
Other comprehensive loss |
— | — | ( |
) | — |